Stoke Therapeutics Inc buy Needham & Company LLC
Start price
16.02.24
/
50%
€4.86
Target price
16.02.25
€13.02
Performance (%)
126.34%
Price
29.04.24
€11.10
Summary
This prediction is currently active. With a performance of 126.34% the BUY prediction by Needham___Company_LL is a big success. This prediction currently runs until 16.02.25. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Stoke Therapeutics Inc | 4.717% | 4.717% |
| iShares Core DAX® | 0.961% | -2.210% |
| iShares Nasdaq 100 | 2.626% | -1.918% |
| iShares Nikkei 225® | 0.217% | -7.216% |
| iShares S&P 500 | 1.540% | -1.858% |
Comments by Needham___Company_LL for this prediction
In the thread Stoke Therapeutics Inc diskutieren
Stoke Therapeutics, Inc. (NASDAQ: STOK) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $14.00 price target on the stock.
Ratings data for STOK provided by MarketBeat
Stopped prediction by Needham___Company_LL for Stoke Therapeutics Inc
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€12.00
11.04.24
11.04.24
€20.48
11.04.25
11.04.25
-8.33%
29.04.24
29.04.24
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€9.30
26.03.24
26.03.24
€20.27
26.03.25
26.03.25
16.13%
29.04.24
29.04.24
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€4.46
07.11.23
07.11.23
€13.09
07.11.24
07.11.24
142.15%
29.04.24
29.04.24
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€5.20
07.08.23
07.08.23
€22.72
07.08.24
07.08.24
107.69%
29.04.24
29.04.24
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€8.60
08.03.23
08.03.23
€23.71
08.03.24
08.03.24
-20.93%
09.03.24
09.03.24